Асатурова А. В.^{1, 2}, Бадлаева А. С.¹, Трегубова А. В.¹, Ежова Л. С.¹, Буланов Д. В.²

¹ФГБУ «Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии им. В. И. Кулакова» Минздрава России; Россия, 117513 Москва, ул. Академика Опарина, 4;

²ФГАОУ ВО «Российский национальный исследовательский медицинский университет им. Н. И. Пирогова» Минздрава России; Россия, 117997 Москва, ул. Островитянова, 1

1. Mazur M. T. Atypical polypoid adenomyomas of the endometrium. Am J Surg Pathol 1981;5(5):473–82.

2. Delprado W. J., Stevens S. M. B., Baird P. J. Atypical polypoid adenomyoma: a case report with ultrastructural examination. Pathology 1985;17(3):522–5.

3. Biasioli A., Londero A. P., Orsaria M. et al. Atypical polypoid adenomyoma follow-up and management: Systematic review of case reports and series and meta-analysis. Medicine. Wolters Kluwer Health 2020;99(26):E20491.

4. Wang X., Guo Y. Clinical analysis of 44 cases of atypical polypoid adenomyoma of the uterus. BMC Womens Health. BioMed Central Ltd 2022;22(1):1–8.

5. Sun Y., Tian L., Liu G. A clinicopathological review of 203 cases of atypical polypoid adenomyoma of the uterus. J Clin Med MDPI 2023;12(4):1511.

6. Raffone A., Travaglino A., Saccone G. et al. Management of women with atypical polypoid adenomyoma of the uterus: A quantitative systematic review. Acta Obstet Gynecol Scand. John Wiley & Sons, Ltd 2019;98(7):842–55.

7. Aggarwal N., Bhargava R., Elishaev E. Uterine adenosarcomas: diagnostic use of the proliferation marker Ki-67 as an adjunct to morphologic diagnosis. Int J Gynecol Pathol 2012;31(5):447–52.

8. Terada T. Atypical polypoid adenomyoma of the uterus: an immunohistochemical study on 5 cases. Ann Diagn Pathol 2011;15(5):338–41.

9. Horita A., Kurata A., Maeda D. et al. Immunohistochemical characteristics of atypical polypoid adenomyoma with special reference to H-caldesmon. Int J Gynecol Pathol 2011;30(1):64–70.

10. Travaglino A., Raffone A., Saccone G. et al. Immunophenotype of atypical polypoid adenomyoma of the uterus: Diagnostic value and insight on pathogenesis. Appl Immunohistochem Mol Morphol 2020;28(8):646–53.

11. Němejcová K. et al. Atypical polypoid adenomyoma of the uterus: An immunohistochemical and molecular study of 21 cases. Am J Surg Pathol 2015;39(8):1148–55.

12. Chen H., Strickland A. L., Castrillon D. H. Histopathologic diagnosis of endometrial precancers: Updates and future directions. Semin Diagn Pathol W. B. Saunders 2022;39(3):137–47.

13. Domeniconi L., Amadori A., Maniglio P. et al. Atypical polypoid adenomyoma of the endometrium: diagnosis and treatment. A case report. Pathologica. Pacini Editore 2020;112(4):214.

14. Ota S., Catasus L., Matias-Guiu X. Molecular pathology of atypical polypoid adenomyoma of the uterus. Hum Pathol W. B. Saunders 2003;34(8):784–8.

15. Soslow R. A., Chung M. H., Rouse R. V. et al. Atypical polypoid adenomyofibroma versus well-differentiated endometrial carcinoma with prominent stromal matrix: an immunohistochemical study. Int J Gynecol Pathol 1996;15(3):209–16.

16. Lu B., Yu M., Shi H. et al. Atypical polypoid adenomyoma of the uterus: A reappraisal of the clinicopathological and immunohistochemical features. Pathol Res Pract 2019;215(4):766–71.

17. Takahashi H., Yoshida T., Matsumoto T. et al. Frequent β-catenin gene mutations in atypical polypoid adenomyoma of the uterus. Hum Pathol 2014;45(1):33–40.

18. Houghton O., Connolly L. E., McCluggage W. G. Morules in endometrioid proliferations of the uterus and ovary consistently express the intestinal transcription factor CDX2. Histopathology 2008;53(2):156–65.

19. McCluggage G. W., De Vijver V. K. SATB2 is consistently expressed in squamous morules associated with endometrioid proliferative lesions and in the stroma of atypical polypoid adenomyoma. Int J Gynecol Pathol 2019;38(5):397–403.

20. Chiarelli S., Buriticá C., Litta P. et al. An immunohistochemical study of morules in endometrioid lesions of the female genital tract: CD10 is a characteristic marker of morular metaplasia. Clin Cancer Res 2006;12(14, Pt 1):4251–6.

21. Fukunaga M., Endo Y., Ushigome S. et al. Atypical polypoid adenomyomas of the uterus. Histopathology 1995;27(1):35–42.

22. Shetty D. S., Gosavi A. V., Murarkar P. S. et al. Great mimickers: Tumor-like lesions of uterine corpus. Int J Health Sci Qassim University 2020;14(2):18.

23. Habiba M., Benagiano G. Classifying adenomyosis: Progress and challenges. Public Health 2021;(18):12386.

24. Wang X., Zhang H., Xu J. et al. The typical polypoid adenomyoma is a special form of endometrial polyp: a case-controlled study with a large sample size. Eur J Med Res BMC 2023;28(1):308.

25. Ben-Arie A., Goldchmit C., Laviv Y. et al. The malignant potential of endometrial polyps. European Journal of Obstetrics and Gynecology and Reproductive Biology. Elsevier Ireland Ltd 2004;115(2):206–10.

26. Jiang J. Endometrial polyps. Am J Obstet Gynecol 2022;226(5):734–5.

27. Silverberg S. G. Problems in the Differential Diagnosis of Endometrial Hyperplasia and Carcinoma. Modern Pathology. Elsevier 2000;13(3):309–27.

28. McCluggage W. G. A practical approach to the diagnosis of mixed epithelial and mesenchymal tumours of the uterus. Modern Pathology 2016;29(1):78–91.

29. Strickland K. C., Yuan L., Quade B. J. et al. Clinicopathological and immunohistochemical features of uterine adenomyomatous polyps. Hum Pathol 2019;84:239–45.

30. Worrell H. I., Sciallis A. P., Skala S. L. Patterns of SATB2 and p16 reactivity aid in the distinction of atypical polypoid adenomyoma from myoinvasive endometrioid carcinoma and benign adenomyomatous polyp on endometrial sampling. Histopathology 2021;79(1):96–105.

31. Kihara A., Amano Y., Yoshimoto T. et al. Stromal p16 expression helps distinguish atypical polypoid adenomyoma from myoinvasive endometrioid carcinoma of the uterus. Am J Surg Pathol 2019;43(11):1526–35.

32. Ohishi Y., Kaku T., Kobayashi H. et al. CD10 immunostaining distinguishes atypical polypoid adenomyofibroma (atypical polypoid adenomyoma) from endometrial carcinoma invading the myometrium. Hum Pathol 2008;39(10):1446–53.

33. Zhang H. K., Chen W. D. Atypical polypoid adenomyomas progressed to endometrial adenocarcinomas. Arch Gynecol Obstet 2012;286(3):707–10.

34. Solima E., Liprandi V., Belloni G.M. et al. Recurrent atypical polypoid adenomyoma and pregnancy: A new conservative approach with levonorgestrel-releasing intrauterine system. Gynecol Oncol Rep Elsevier 2017;21:84.

35. Edwards J. M., Alsop S., Modesitt S. C. Coexisting atypical polypoid adenomyoma and endometrioid endometrial carcinoma in a young woman with cowden syndrome: Case report and implications for screening and prevention. Gynecol Oncol Case Rep Elsevier 2012;2(2):29.

36. Sonoyama A., Kanda M., Ojima Y. et al. Coexistence of endometrioid adenocarcinoma in atypical polypoid adenomyoma. Kobe J Med Sci 2014;60(3):74–7.

37. Ma B., Zhu Y., Liu Y. Management of atypical polypoid adenomyoma of the uterus: A single center’s experience. Medicine. Wolters Kluwer Health 2018;97:12.

38. Wang X., Guo Y. Clinical analysis of 44 cases of atypical polypoid adenomyoma of the uterus. BMC Womens Health 2022;22(1).

39. Chiyoda T., Lin B.-L., Saotome K. et al. Hysteroscopic transcervical resection for atypical polypoid adenomyoma of the uterus: A valid, fertility-preserving option. J Minim Invasive Gynecol 2018;25(1):163–9.e1.